These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 3125434
1. Factors associated with early remission of type I diabetes in children treated with cyclosporine. Bougneres PF, Carel JC, Castano L, Boitard C, Gardin JP, Landais P, Hors J, Mihatsch MJ, Paillard M, Chaussain JL. N Engl J Med; 1988 Mar 17; 318(11):663-70. PubMed ID: 3125434 [Abstract] [Full Text] [Related]
5. Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes. Karges B, Schwandt A, Heidtmann B, Kordonouri O, Binder E, Schierloh U, Boettcher C, Kapellen T, Rosenbauer J, Holl RW. JAMA; 2017 Oct 10; 318(14):1358-1366. PubMed ID: 29049584 [Abstract] [Full Text] [Related]
6. Increase in remission rate in newly diagnosed type I diabetic subjects treated with azathioprine. Harrison LC, Colman PG, Dean B, Baxter R, Martin FI. Diabetes; 1985 Dec 10; 34(12):1306-8. PubMed ID: 3905463 [Abstract] [Full Text] [Related]
11. [Factors involved in ketoacidosis at the onset of type 1 diabetes in childhood]. Młynarski W, Zmysłowska A, Kubryn I, Perenc M, Bodalski J. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2003 Dec 10; 9(1):23-8. PubMed ID: 12831634 [Abstract] [Full Text] [Related]
12. Sustained initial remission induced by intensive insulin treatment in type I diabetes. Possible role of the genetic background. Vague P, Vialettes B, Lassmann V, Moulin JP, Mercier P. Acta Diabetol Lat; 1985 Dec 10; 22(4):295-304. PubMed ID: 3914156 [Abstract] [Full Text] [Related]
13. Effects of immunosuppression with cyclosporine in insulin-dependent diabetes mellitus of recent onset: the Canadian open study at 44 months. Dupré J, Stiller CR, Gent M, Donner A, von Graffenreid B, Murphy G, Heinrichs D, Jenner MR, Keown PA, Laupacis A. Transplant Proc; 1988 Jun 10; 20(3 Suppl 4):184-92. PubMed ID: 3289204 [No Abstract] [Full Text] [Related]
14. Cyclosporine A for the treatment of new-onset insulin-dependent diabetes mellitus. Chase HP, Butler-Simon N, Garg SK, Hayward A, Klingensmith GJ, Hamman RF, O'Brien D. Pediatrics; 1990 Mar 10; 85(3):241-5. PubMed ID: 2304776 [Abstract] [Full Text] [Related]
15. C-peptide in juvenile diabetics beyond the postinitial remission period. Relation to clinical manifestations at onset of diabetes, remission and diabetic control. Ludvigsson J, Heding LG, Larsson Y, Leander E. Acta Paediatr Scand; 1977 Mar 10; 66(2):177-84. PubMed ID: 402787 [Abstract] [Full Text] [Related]
16. Young children (<5 yr) and adolescents (>12 yr) with type 1 diabetes mellitus have low rate of partial remission: diabetic ketoacidosis is an important risk factor. Bowden SA, Duck MM, Hoffman RP. Pediatr Diabetes; 2008 Jun 10; 9(3 Pt 1):197-201. PubMed ID: 18547233 [Abstract] [Full Text] [Related]
18. Factors Influencing Frequency and Duration of Remission in Children and Adolescents Newly Diagnosed with Type 1 Diabetes. Kara Ö, Esen İ, Tepe D. Med Sci Monit; 2018 Aug 28; 24():5996-6001. PubMed ID: 30153246 [Abstract] [Full Text] [Related]
19. Cyclosporin-induced remission of IDDM after early intervention. Association of 1 yr of cyclosporin treatment with enhanced insulin secretion. The Canadian-European Randomized Control Trial Group. Diabetes; 1988 Nov 28; 37(11):1574-82. PubMed ID: 2903105 [Abstract] [Full Text] [Related]